Pathological diagnosis industry analysis, a potential market of more than 40billion!
2021-05-23 14:24:19
From the perspective of global market scale, it is estimated that by 2024, the market scale of pathology will reach US $44.4 billion from US $30.3 billion in 2019, with a compound annual growth rate of 6.1% from 2019 to 2024; In terms of the domestic market scale, the potential market of pathology industry is over 40billion yuan, including 2-3billion yuan in histopathology market, 30billion yuan in cell pathology, 4billion yuan in immunohistochemical pathology and 5billion yuan in molecular pathology.
Pathological examination is the gold standard of tumor diagnosis. It is a medical science that reveals the occurrence and development of diseases by studying the changes in the etiology, pathogenesis, morphological structure, function and metabolism of diseases, so as to clarify the nature of diseases. Pathological examination is widely used in the field of tumor. Although there are many forms of tumor diagnosis, pathological report is now recognized as the "final judgment" of tumor and the "gold standard" of tumor diagnosis.
According to the different stages of development, pathology is mainly divided into traditional pathological techniques (histopathology, cell pathology), immunohistochemical pathology and molecular pathology. The traditional histopathology is based on the level of tissue and cell, which can judge the nature of the disease (inflammatory disease or tumor type disease, benign tumor or malignant tumor, etc.) through the microscopic diagnosis of the pathologist; Based on the protein level, immunohistochemical pathology can further judge the tumor tissue source, primary location, pathological classification, residual marginal cancer cells, etc. in addition to the role of diagnosis, it can also guide the prognosis; Molecular pathology is based on the nucleic acid molecular level, which can determine the type of gene mutation of tumor and be used for the guidance of subsequent targeted drugs to achieve precision medicine.
Pathological examination is the gold standard of tumor diagnosis. It is a medical science that reveals the occurrence and development of diseases by studying the changes in the etiology, pathogenesis, morphological structure, function and metabolism of diseases, so as to clarify the nature of diseases. Pathological examination is widely used in the field of tumor. Although there are many forms of tumor diagnosis, pathological report is now recognized as the "final judgment" of tumor and the "gold standard" of tumor diagnosis.
According to the different stages of development, pathology is mainly divided into traditional pathological techniques (histopathology, cell pathology), immunohistochemical pathology and molecular pathology. The traditional histopathology is based on the level of tissue and cell, which can judge the nature of the disease (inflammatory disease or tumor type disease, benign tumor or malignant tumor, etc.) through the microscopic diagnosis of the pathologist; Based on the protein level, immunohistochemical pathology can further judge the tumor tissue source, primary location, pathological classification, residual marginal cancer cells, etc. in addition to the role of diagnosis, it can also guide the prognosis; Molecular pathology is based on the nucleic acid molecular level, which can determine the type of gene mutation of tumor and be used for the guidance of subsequent targeted drugs to achieve precision medicine.
